Evidence map›Paper›PMID 28972578›Full record

ArticleScientific data2017

Linking FANTOM5 CAGE peaks to annotations with CAGEscan.

Nicolas Bertin, Mickaël Mendez, Akira Hasegawa, Marina Lizio, Imad Abugessaisa, Jessica Severin, Mizuho Sakai-Ohno, Timo Lassmann, Takeya Kasukawa, Hideya Kawaji and 4 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nicolas BertinRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.ORCID 0000-0002-9835-9606
Mickaël MendezRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Akira HasegawaRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Marina LizioRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.ORCID 0000-0001-7337-7325
Imad AbugessaisaRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.ORCID 0000-0001-7458-801X
Jessica SeverinRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Mizuho Sakai-OhnoRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Timo LassmannRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Takeya KasukawaRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Hideya KawajiRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.ORCID 0000-0002-0575-0308
Yoshihide HayashizakiRIKEN Omics Science Center, Yokohama 230-0045, Japan.
Alistair R R ForrestRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Piero CarninciRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.
Charles PlessyRIKEN Center for Life Science Technologies, Division of Genomics Technologies, Yokohama 230-0045, Japan.ORCID 0000-0001-7410-6295

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FANTOM5 expression atlas is a quantitative measurement of the activity of nearly 200,000 promoter regions across nearly 2,000 different human primary cells, tissue types and cell lines. Generation of this atlas was made possible by the use of CAGE, an experimental approach to localise transcription start sites at single-nucleotide resolution by sequencing the 5' ends of capped RNAs after their conversion to cDNAs. While 50% of CAGE-defined promoter regions could be confidently associated to adjacent transcriptional units, nearly 100,000 promoter regions remained gene-orphan. To address this, we used the CAGEscan method, in which random-primed 5'-cDNAs are paired-end sequenced. Pairs starting in the same region are assembled in transcript models called CAGEscan clusters. Here, we present the production and quality control of CAGEscan libraries from 56 FANTOM5 RNA sources, which enhances the FANTOM5 expression atlas by providing experimental evidence associating core promoter regions with their cognate transcripts.

Indexed as

Promoter Regions, GeneticTranscription, GeneticDNA, ComplementaryHumansOrgan SpecificitySequence Analysis, RNATranscription Initiation SiteDNA, Complementary

Identifiers

PMID28972578
PMCPMC5625555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.